Found: 24
Select item for more details and to access through your institution.
Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2437, doi. 10.1007/s00432-022-04084-0
- By:
- Publication type:
- Article
Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA.
- Published in:
- Avicenna Journal of Medical Biotechnology, 2019, v. 11, n. 1, p. 72
- By:
- Publication type:
- Article
Epitope mapping of neutralising anti‐SARS‐CoV‐2 monoclonal antibodies: Implications for immunotherapy and vaccine design.
- Published in:
- Reviews in Medical Virology, 2022, v. 32, n. 5, p. 1, doi. 10.1002/rmv.2347
- By:
- Publication type:
- Article
SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design.
- Published in:
- Reviews in Medical Virology, 2023, v. 33, n. 3, p. 1, doi. 10.1002/rmv.2431
- By:
- Publication type:
- Article
Cross talk between hepatitis B virus and innate immunity of hepatocytes.
- Published in:
- Reviews in Medical Virology, 2022, v. 32, n. 1, p. 1, doi. 10.1002/rmv.2256
- By:
- Publication type:
- Article
Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection.
- Published in:
- Reviews in Medical Virology, 2018, v. 28, n. 6, p. N.PAG, doi. 10.1002/rmv.2007
- By:
- Publication type:
- Article
Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.
- Published in:
- Neurotoxicity Research, 2020, v. 37, n. 3, p. 578, doi. 10.1007/s12640-019-00124-9
- By:
- Publication type:
- Article
Epitope Mapping of Tetanus Toxin by Monoclonal Antibodies: Implication for Immunotherapy and Vaccine Design.
- Published in:
- Neurotoxicity Research, 2020, v. 37, n. 2, p. 239, doi. 10.1007/s12640-019-00096-w
- By:
- Publication type:
- Article
Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab).
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2023, v. 31, n. 2, p. 221, doi. 10.1007/s40199-023-00477-9
- By:
- Publication type:
- Article
Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 697, doi. 10.1007/s10637-020-01048-4
- By:
- Publication type:
- Article
Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 171, doi. 10.1007/s10637-017-0518-0
- By:
- Publication type:
- Article
Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5827, doi. 10.3390/cancers14235827
- By:
- Publication type:
- Article
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.
- Published in:
- European Journal of Microbiology & Immunology, 2024, v. 14, n. 3, p. 228, doi. 10.1556/1886.2024.00045
- By:
- Publication type:
- Article
A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.600883
- By:
- Publication type:
- Article
Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 3, p. 347, doi. 10.1007/s00280-021-04390-3
- By:
- Publication type:
- Article
Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice.
- Published in:
- Iranian Journal of Immunology, 2024, v. 21, n. 1, p. 1, doi. 10.22034/iji.2024.101060.2728
- By:
- Publication type:
- Article
Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue Samples.
- Published in:
- Iranian Journal of Immunology, 2023, v. 20, n. 2, p. 177, doi. 10.22034/iji.2023.96926.2469
- By:
- Publication type:
- Article
Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies.
- Published in:
- Iranian Journal of Immunology, 2022, v. 19, n. 3, p. 278, doi. 10.22034/iji.2022.94266.2298
- By:
- Publication type:
- Article
Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody.
- Published in:
- Iranian Journal of Immunology, 2019, v. 16, n. 1, p. 26, doi. 10.22034/IJI.2019.39404
- By:
- Publication type:
- Article
Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro.
- Published in:
- Iranian Journal of Immunology, 2017, v. 14, n. 3, p. 200
- By:
- Publication type:
- Article
Analysis of Knowledge, Attitudes, and Prevalence of Hepatitis B and C Seromarkers Among Barbers in Tehran.
- Published in:
- Hepatitis Monthly, 2016, v. 16, n. 9, p. 1, doi. 10.5812/hepatmon.39416
- By:
- Publication type:
- Article
Localization of immunodominant epitopes within the 'a' determinant of hepatitis B surface antigen using monoclonal antibodies.
- Published in:
- Archives of Virology, 2016, v. 161, n. 10, p. 2765, doi. 10.1007/s00705-016-2980-y
- By:
- Publication type:
- Article
Human Leukocyte Antigens Influence the Antibody Response to Hepatitis B Vaccine.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 2014, v. 29, n. 5, p. 1083, doi. 10.1111/jgh.12483
- By:
- Publication type:
- Article